334 related articles for article (PubMed ID: 19643213)
1. Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis.
Gaston JS; Inman RD; Ryan ET; Venkatesan MM; Barry EM; Hale TL; Bourgeois AL; Walker RI
Vaccine; 2009 Sep; 27(40):5432-4. PubMed ID: 19643213
[TBL] [Abstract][Full Text] [Related]
2. Recent progress towards development of a Shigella vaccine.
Camacho AI; Irache JM; Gamazo C
Expert Rev Vaccines; 2013 Jan; 12(1):43-55. PubMed ID: 23256738
[TBL] [Abstract][Full Text] [Related]
3. Shigellosis.
Niyogi SK
J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
[TBL] [Abstract][Full Text] [Related]
4. Shigellosis: the current status of vaccine development.
Kweon MN
Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
[TBL] [Abstract][Full Text] [Related]
5. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
Walker RI
Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.
Levine MM; Kotloff KL; Barry EM; Pasetti MF; Sztein MB
Nat Rev Microbiol; 2007 Jul; 5(7):540-53. PubMed ID: 17558427
[TBL] [Abstract][Full Text] [Related]
7. HLA-B27/microbial mimicry: an in vivo analysis.
Kapasi K; Chui B; Inman RD
Immunology; 1992 Nov; 77(3):456-61. PubMed ID: 1478690
[TBL] [Abstract][Full Text] [Related]
8. Live-attenuated Shigella vaccines.
Venkatesan MM; Ranallo RT
Expert Rev Vaccines; 2006 Oct; 5(5):669-86. PubMed ID: 17181440
[TBL] [Abstract][Full Text] [Related]
9. Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies.
Raybourne RB; Bunning VK; Williams KM
J Immunol; 1988 May; 140(10):3489-95. PubMed ID: 3283236
[TBL] [Abstract][Full Text] [Related]
10. The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background.
Roberts F; Jennison AV; Verma NK
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):285-9. PubMed ID: 15963704
[TBL] [Abstract][Full Text] [Related]
11. Inactivated and subunit vaccines to prevent shigellosis.
Kaminski RW; Oaks EV
Expert Rev Vaccines; 2009 Dec; 8(12):1693-704. PubMed ID: 19943764
[TBL] [Abstract][Full Text] [Related]
12. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies.
Camacho AI; Souza-Rebouças J; Irache JM; Gamazo C
Methods; 2013 May; 60(3):264-8. PubMed ID: 23046911
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of Shigella and of Shigella vaccine among rural Chinese: compatibility with Western models of behavioral change.
Youlong G; Stanton BF; Von Seidlen L; Xueshan F; Nyamette A
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):97-108. PubMed ID: 15272751
[TBL] [Abstract][Full Text] [Related]
15. Whole genome analysis to detect potential vaccine-induced changes on Shigella sonnei genome.
Behar A; Fookes MC; Goren S; Thomson NR; Cohen D
Vaccine; 2015 Jun; 33(26):2978-83. PubMed ID: 25936664
[TBL] [Abstract][Full Text] [Related]
16. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27.
Schiellerup P; Krogfelt KA; Locht H
J Rheumatol; 2008 Mar; 35(3):480-7. PubMed ID: 18203313
[TBL] [Abstract][Full Text] [Related]
17. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
Jennison AV; Roberts F; Verma NK
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility and HLA-B27 in post-dysenteric arthropathies.
van Bohemen CG; Lionarons RJ; van Bodegom P; Dinant HJ; Landheer JE; Nabbe AJ; Grumet FC; Zanen HC
Immunology; 1985 Oct; 56(2):377-9. PubMed ID: 3902627
[TBL] [Abstract][Full Text] [Related]
19. [Reactive arthritis in children].
Piussan C; Pautard-Muchemble B; Pautard JC; Lenaerts C; Boudailliez B; Risbourg B
Sem Hop; 1984 Jan; 60(1):52-62. PubMed ID: 6320436
[TBL] [Abstract][Full Text] [Related]
20. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
